Author: McIlleron, Helen
Similar Items: Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- Determination of Rifapentine and 25-O-desacetyl Rifapentine from 100 µl human breastmilk by LC-MS/MS using protein precipitation and solid phase extraction
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling
- Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia